Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...

There is always a challenging moment in every investor’s favorite stock and portfolio, especially when said businesses are ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Pharma giants are sweating on the results of a federal government request for guidance on adding weight loss drugs to the ...

CVS says the decision to cover Wegovy and exclude Zepbound is "forcing the drug manufacturers to compete with one another" and will encourage both Eli Lilly and Novo Nordisk to lower prices for their ...

Our writer reveals what he thinks is the most exciting from the four investments he made in his Stocks and Shares ISA last ...

THUNDER BAY — Novo Nordisk Canada has issued a voluntary recall of its semiglutide injections, Ozempic, due to potential ...